Observatoire des droits humains (anglais seulement)

Researchers: Ebola Vaccine Trials 'Very Satisfactory' So Far

(Version anglaise seulement)

Almost 200 people have received GlaxoSmithKline's experimental Ebola vaccine in trials in the United States, Britain, Mali and Switzerland, and the safety data so far are “very satisfactory,” scientists said on Monday. The trials, which began just over two months ago, have been using healthy volunteers, rather than patients with Ebola, to test whether the vaccine is safe for humans. The experimental shot uses a single Ebola virus gene from a chimpanzee virus to generate an immune...

Lire l'article complet